HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
© 2015 Elsevier Ltd. Background: Pre-exposure prophylaxis (PrEP) with oral emtricitabine and tenofovir disoproxil fumarate is used to prevent the sexual acquisition of HIV in groups at high risk such as transgender women. We used data from the iPrEx study to assess PrEP efficacy, effectiveness, and...
Saved in:
Main Authors: | Madeline B. Deutsch, David V. Glidden, Jae Sevelius, Joanne Keatley, Vanessa McMahan, Juan Guanira, Esper G. Kallas, Suwat Chariyalertsak, Robert M. Grant, Javier Lama, Mauro Schechter, Valdilea Veloso, Linda Gail Bekker, Kenneth Mayer, Susan Buchbinder, Orlando Montoya, Martin Casapia, Sybil Hosek, Albert Liu, Rivet Amico, Kimberly Koester, Kathleen Mulligan |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959932232&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44053 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
by: Madeline B. Deutsch, et al.
Published: (2018) -
Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
by: Albert Liu, et al.
Published: (2018) -
Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
by: Albert Liu, et al.
Published: (2018) -
Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
by: Marc M. Solomon, et al.
Published: (2018) -
Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
by: Marc M. Solomon, et al.
Published: (2018)